Blood Biomarkers in Suicidal Behaviour

NACompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

September 23, 2016

Primary Completion Date

June 24, 2020

Study Completion Date

June 24, 2020

Conditions
Major Depression
Interventions
OTHER

Blood sample for genetic purpose

"All the participants will performed the same evaluations and blood analysis :~* A clinical assessment by psychiatrist~* Self report questionnaires for the assessment of a potential mood disorder and history of SB, moral/physical pain, personality traits…~* A neuropsychological assessment for the evaluations of cognitive performances~* A routine blood sampling to the realization of a standard blood test~* A specific blood sampling (PAXgene® tubes) to extract total RNA of blood cells and measure the expression of ADARS RNA and editing of the PDE8A transcript."

Trial Locations (1)

34295

University Hospital, Montpêllier

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Sys2Diag, Mixt laboratory CNRS/Alcediag, Montpellier

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT02855918 - Blood Biomarkers in Suicidal Behaviour | Biotech Hunter | Biotech Hunter